Topic 10: Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes (RIA)

HORIZON-MISS-2027-02-CANCER-03:
Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes (RIA)

Deadline: 21.09.2027


♦ Type of MGA: Lump Sum Grant